Prolonged grief disorder (PGD), a condition characterized by an extended and intense form of mourning, has become a subject of increasing interest within the field of mental health.
PGD is thought to affect a significant number of individuals who struggle to adapt to life after the death of a loved one. While the estimated prevalence varies across studies, it is believed that between 10 and 20 percent of bereaved individuals may experience PGD. These symptoms can include a persistent yearning and longing for the deceased, preoccupation with thoughts and memories of the lost loved one, difficulty accepting the death, and a sense of purposelessness or emptiness.
The controversy surrounding PGD revolves around its classification as a separate and unique diagnosis. Skeptics argue that grief is a natural response to loss and that medicalizing the grieving process pathologizes a normal human experience. They suggest that grief should not be pathologized unless it becomes severe, debilitating, or significantly impacts an individual's ability to function in daily life.
On the other hand, proponents of including PGD as a distinct diagnosis argue that it acknowledges and validates the unique and prolonged suffering that some individuals experience. They emphasize that PGD requires specialized attention and interventions beyond the usual support provided during the grief process
To address the ongoing debate, the latest edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) introduced the diagnosis of Persistent Complex Bereavement Disorder (PCBD) in March 2022. The inclusion of this disorder remains controversial, with ongoing discussions among professionals in the field.